WELCOME TO CRYO-SAVE
At Cryo-Save, we have been storing umbilical cord stem cells for families all over the world since the year 2000. We are the leading family stem cell bank in Europe and Africa, the fastest growing in the world and, in 2013, we stored our 250,000th sample.
Cryo-Save South Africa offers both local and international storage options in either Pretoria or Belgium, for both cord blood and cord tissue.
THE BENEFITS OF CORD BLOOD BANKING
Umbilical cord blood is a rich source of haematopoietic (blood-forming) stem cells. Cord blood transplantation is an established alternative to bone marrow and peripheral blood stem cell transplantation and, to date, over 35,000 allogeneic cord blood transplants have been performed worldwide.
Umbilical cord blood and cord tissue stem cells have unique properties:
Stem cells present in cord blood are ‘younger’ than those in bone marrow and have a significantly greater capacity to multiply and grow (proliferate) and to differentiate into different types of cells.
Stem cells with this high proliferative potential are present in greater numbers in cord blood (more than eight times higher than in bone marrow).
Umbilical cord blood stem cells have a higher expression of certain ‘adhesion’ molecules which enables them to ‘home-in’ to where they are needed.
They have ‘younger’ DNA and are therefore able to continue to form the elements of blood for longer.
Stem cells in cord blood which belong to the immune system have not yet been exposed to outside factors (i.e. they are more immunologically ‘naïve’).
Blood-forming stem cells are less likely to cause complications (graft-versus-host disease) in allogeneic (donor to patient) transplants than other adult stem cells.
Increasing the number of umbilical cord blood haematopoietic stem cells prior to transplantation (stem cell ‘expansion’) is proving to be successful in clinical trials.
Cord tissue stem cells are able to transform into numerous types of cells including muscle, bone, cartilage and nerve cells.